NX
NEXGEL, Inc.
NXGL · NASDAQ
$0.32 -6.64% (-$0.02)
1M -12.67%
Market Cap $2.68M
P/E Ratio -
Div. Yield -
ROE 133.10%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.54x
P/S 0.22x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 16.42%
Rev. growth 77.33%
FCF growth N/A
Profitability
14 /100
Weak Net margin 51.26%
Op. margin 44.77%
FCF margin 27.10%
Quality
6 /100
Poor ROE 133.10%
ROA 23.39%
Asset turnover 0.46x
Debt
17 /100
High Current ratio 0.43x
Int. coverage -1.73x
Debt/Equity 1.49x
Stability
56 /100
Moderate Rev. volatility 43.55%
EPS volatility 11.74%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NXGL
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Adam R. Levy
Employees
19
Headquarters
Langhorne
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report